New

Pre Clinical CROs Market

2021

Pre Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geography

Publication Month: Sep 2019 | Report Code: TIPRE00003316 | No. of Pages: 139 | Category: Pharmaceuticals | Status: Published

Market Insights

Pre Clinical CROs Market to Reach US$ 8,412.9 Mn at a CAGR of 8.1% in 2027 | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Pre-Clinical CROs in healthcare market was valued at US$ 4,282.4 million in 2018 and it is projected to reach US$ 8,412.9 million by 2027; it is expected to grow at a CAGR of 8.1% from 2019 to 2027.

A pre-clinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. Majority of the sponsoring organizations do not have the requisite facilities and staff for conducting tests under special supervision and appropriate set-up for particular drugs and medical devices and thus choose to contract research of this kind. The growth of the Pre-Clinical CROs in healthcare market is attributed to the increasing R&D expenditures and high cost of drug development process in the developed countries have been boosting the market over the years. However, stringent regulations for conduction of clinical trials and variations in the GMP guidelines across countries around the globe are likely to have a negative impact on the growth of the market in the coming years.

The Pre-Clinical CROs in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Pre-Clinical CROs in Healthcare Market
Lucrative Regions for Pre-Clinical CROs in Healthcare Market

Get more information on this report :


Market Insights

Growing Applications of Pre-Clinical CROs in Healthcare to Drive Pre-Clinical CROs in Healthcare Market Growth

Research & development (R&D) is a significant and essential part of a company’s business. Pharmaceutical and biotech companies majorly focus on research and development (R&D) to come up with new molecules for various therapeutic applications with the most significant medical and commercial potential. The companies invest majorly on the R&Ds intending to deliver high quality and innovative products to the market.

R&D investments made by biopharmaceutical companies have increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion in 2012 to US$ 58.8 billion in 2015 Research and development expenditures are usually incurred during processes of discovering, testing, and developing new products, upfront payments, and milestones, improving existing outcomes, as well as demonstrating product efficacy and regulatory compliance before launch. As per the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 in the pharmaceuticals and biotechnology industry grew by approximately 8.7% compared to the expenses in 2013. Moreover, in the US, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in the US it accounted for approximately 17%, and in the European Union it was registered to be around 13% in the year 2014.

Drug development and discovery is a time-consuming and expensive process. The process from early detection or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Hence, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) to save the cost and time, which is expected to drive the growth of the market.

A rise in outsourcing activities by pharmaceutical companies has been witnessed during recent years. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, sophisticated technologies, and an unstable economic environment. Companies generally outsource R&D tasks which include a broad range of activities such as, fundamental research to late-stage development: hit exploration and lead optimization, target validation, genetic engineering, assay development, safety and efficacy tests in animal models, and clinical trials which involve humans.

The major factors driving the growth of outsourcing activities by companies are, cutting costs, need for innovations, increased speed and agility, and accessing specialized knowledge and technologies. A decreasing percentage of profits has become a primary concern for pharmaceutical companies over the past decade. As per an analysis by PhRMA, around $0.8 to $1.7 billion is estimated to be invested by the pharmaceutical industry in R&D to bring a new drug to market. Hence, with an increase in the R&D expenditure, the need for pre-clinical services is expected to drive the growth of global pre-clinical CROs market.

Service-Based Insights

In terms of service, the Pre-Clinical CROs in healthcare market is segmented into bioanalysis & dmpk studies, toxicology, others. The toxicology segment held a largest share of the market in 2018.

Pre-Clinical CROs in Healthcare Market, by Service – 2018 and 2027
Pre-Clinical CROs in Healthcare Market, by Service – 2018 and 2027

Get more information on this report :



End User-Based Insights

In terms of end user, the Pre-Clinical CROs in healthcare market is segmented into biopharmaceutical companies, government & academic institutes, medical device companies. In 2018, the biopharmaceutical companies segment held the largest share of the market, by end user.

Strategic Insights

The Pre-Clinical CROs in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Pre-Clinical CROs in Healthcare Market – by Service

  • Bio-Analysis and DMPK Studies
  • Toxicology
  • Other Services

Pre-Clinical CROs in Healthcare Market – by End User

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies

Pre-Clinical CROs in Healthcare Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Covance, Inc.
  • Charles River.
  • Eurofins Scientific
  • PRA Health Sciences
  • WuXi AppTec
  • Medpace, Inc.
  • Pharmaceutical Product Development, LLC.
  • Parexel International Corporation
  • ICON Plc
  • MD Biosciences

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Pre Clinical CROs Market – By Service

1.3.2 Global Pre Clinical CROs Market – By End User

1.3.3 Global Pre Clinical CROs Market – By Geography

2. Global Pre Clinical CROs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Pre Clinical CROs Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Expert Opinions

5. Global Pre Clinical CROs Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing R&D Expenditures

5.1.2 Higher Cost of Drug Development Process in Developed Countries

5.2 Key Market Restraint

5.2.1 Dearth of Skilled Professionals

5.3 Key Market Opportunities

5.3.1 Rising Biosimilars and Biologics Market

5.4 Future Trends

5.4.1 Increasing Number of Clinical Trials

5.5 Impact Analysis

6. Pre Clinical CROs Market – Global Analysis

6.1 Global Pre Clinical CROs Market Revenue Forecasts And Analysis

6.2 Global Pre Clinical CROs Market, By Geography - Forecasts And Analysis

6.3 Performance of Key Players

7. Global Pre Clinical CROs Market Analysis– by Service

7.1 Overview

7.2 Global Pre Clinical CROs Market, By Service 2018 & 2027 (%)

7.3 Bio-Analysis and DMPK Studies Market

7.3.1 Overview

7.3.2 Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3 Toxicology Market

7.3.3.1 Overview

7.3.3.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4 Other Services Market

7.3.4.1 Overview

7.3.4.2 Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pre Clinical CROs Market Analysis – by End User

8.1 Overview

8.2 Global Pre Clinical CROs Market, By End User 2018 & 2027 (%)

8.3 Biopharmaceutical Companies Market

8.3.1 Overview

8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Government & Academic Institutes Market

8.4.1 Overview

8.4.2 Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Medical Device Companies Market

8.5.1 Overview

8.5.2 Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Pre Clinical CROs Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1 North America Pre Clinical CROs Market

9.1.1 Overview

9.1.2 North America Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3 North America Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.4 North America Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5 North America Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.1.6 US Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1 US Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2 US Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.6.3 US Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7 Canada Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1 Canada Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2 Canada Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.7.3 Canada Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8 Mexico Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1 Mexico Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2 Mexico Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.8.3 Mexico Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2 Europe Pre Clinical CROs Market

9.2.1 Overview

9.2.2 Europe Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3 Europe Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.4 Europe Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.5 Europe Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.2.6 UK Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1 UK Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2 UK Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.6.3 UK Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.7 Germany Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1 Germany Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2 Germany Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.7.3 Germany Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.8 France Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1 France Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2 France Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.8.3 France Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.9 Italy Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1 Italy Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2 Italy Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.9.3 Italy Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.10 Spain Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.1 Spain Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.2 Spain Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.10.3 Spain Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3 Asia Pacific Pre Clinical CROs Market

9.3.1 Overview

9.3.2 Asia Pacific Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3 Asia Pacific Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.4 Asia Pacific Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.5 Asia Pacific Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.3.6 China Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1 China Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2 China Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.6.3 China Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7 India Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1 India Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2 India Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.7.3 India Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.8 Japan Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1 Japan Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2 Japan Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.8.3 Japan Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.9 Australia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1 Australia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.2 Australia Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.9.3 Australia Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.10 South Korea Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.1 South Korea Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.2 South Korea Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.10.3 South Korea Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4 Middle East & Africa Pre Clinical CROs Market

9.4.1 Overview

9.4.2 Middle East & Africa Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.3 Middle East & Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.4 Middle East & Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.5 Middle East & Africa Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.4.6 South Africa Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1 South Africa Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.2 South Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.6.3 South Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.7 Saudi Arabia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.1 Saudi Arabia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.2 Saudi Arabia Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.7.3 Saudi Arabia Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.8 UAE Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1 UAE Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.2 UAE Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.8.3 UAE Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5 South And Central America Pre Clinical CROs Market

9.5.1 Overview

9.5.2 South and Central America Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3 South and Central America Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.4 South and Central America Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.5 South and Central America Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.5.6 Argentina Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.1 Argentina Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.2 Argentina Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.6.3 Argentina Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.7 Brazil Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1 Brazil Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.2 Brazil Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.7.3 Brazil Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Pre Clinical CROs Market – Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Pre Clinical CROs Market, 2016-2019

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies in the Pre Clinical CROs Market, 2016-2019 (%)

10.4.1 Expansion & Other Activities

10.4.1.1 Recent Expansion & Other Activities By Players In The Pre Clinical CROs Market

10.4.2 Product Launches

10.4.2.1 Recent Product Launches By Players In The Pre Clinical CROs Market

10.5 Inorganic Growth Strategies

10.5.1 Overview

10.6 Inorganic Growth Strategies in the Pre Clinical CROs Market, 2016-2019 (%)

10.6.1 Acquisitions

10.6.1.1 Recent Acquisitions By Players In The Pre Clinical CROs Market

10.6.2 Agreements & Collaborations

10.6.2.1 Recent Agreements & Collaborations By Players In The Pre Clinical CROs Market

10.6.3 Partnerships

10.6.3.1 Recent Partnerships By Players In The Pre Clinical CROs Market

11. Pre Clinical CROs Market–Key Company Profiles

11.1 MD Biosciences, Inc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Services Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 WuXi AppTec

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Overview

11.2.4 Service Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Pharmaceutical Product Development, LLC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Service Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Covance Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Information

11.4.4 Service Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Charles River

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Services Portfolio

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 PRA Health Sciences, Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Overview

11.6.4 Service Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medpace

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Service Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Parexel International Corporation

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Service Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 ICON Plc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Service Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Eurofins Scientific

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. R&D Investments by Major Pharmaceutical Companies

Table 2. R&D Investments by PhRMA Member Companies,2016

Table 3. Number of Studies Registered for Clinical Trials

Table 4. North America Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 5. North America Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 6. US: R&D Investments by Pharmaceutical Companies, (2015-2016)

Table 7. US Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 8. US Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9. Canada Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 10. Canada Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 11. Mexico Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 12. Mexico Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13. Europe Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 14. Europe Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 15. UK Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 16. UK Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17. Germany Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 18. Germany Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 19. France Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 20. France Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21. Italy Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 22. Italy Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 23. Spain Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 24. Spain Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25. Asia Pacific Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 26. Asia Pacific Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 27. China: Major global pharmaceutical companies by R&D investments, 2013

Table 28. China Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 29. China Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 30. India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 31. India Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 32. India Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 33. Japan Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 34. Japan Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 35. Australia Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 36. Australia Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37. South Korea Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 38. South Korea Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 39. Middle East & Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 40. Middle East & Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 41. South Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 42. South Africa Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 43. Saudi Arabia Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 44. Saudi Arabia Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 45. UAE Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 46. UAE Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 47. South and Central America Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 48. South and Central America Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49. Argentina Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 50. Argentina Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 51. Brazil Pre Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 52. Brazil Pre Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 53. Recent Expansion & Other Activities By Players In The Pre Clinical CROs Market

Table 54. Recent Product Launches in the Pre Clinical CROs Market

Table 55. Recent Acquisitions By Players In The Pre Clinical CROs Market

Table 56. Recent Agreements & Collaborations By Players In The Pre Clinical CROs Market

Table 57. Recent Partnerships By Players In The Pre Clinical CROs Market

Table 58. Glossary of Terms, Pre Clinical CROs Market

LIST OF FIGURES

Figure 1. Pre Clinical CROs Market Segmentation

Figure 2. Pre Clinical CROs Market Segmentation, by Region

Figure 3. Global Pre Clinical CROs Market Overview

Figure 4. Imaging Segment Held Largest Share Of The Service Segment In Pre Clinical CROs Market

Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6. Global Pre Clinical CROs Market, By Geography (US$ Mn)

Figure 7. Global Pre Clinical CROs Market- Leading Country Markets (US$ Mn)

Figure 8. Global Pre Clinical CROs Market, Industry Landscape

Figure 9. North America : PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia - Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Number of Approvals for NDA & BLA (2005 to 2016)

Figure 15. Impact Analysis of Driver and Restraints Pertaining to Pre Clinical CROs Market

Figure 16. Global Pre Clinical CROs Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 17. Global Pre Clinical CROs Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 18. Prominent Players in the Pre Clinical CROs Market

Figure 19. Global Pre Clinical CROs Market, by Service 2018 & 2027 (%)

Figure 20. Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Global Pre Clinical CROs Market, by End User 2018 & 2027 (%)

Figure 24. Global Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27. North America Pre Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 28. North America Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. North America Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 30. US Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31. Canada Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32. Mexico Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33. Europe Pre Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 34. Europe Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35. Europe Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 36. UK Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37. Germany Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38. France Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39. Italy Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40. Spain Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41. Asia Pacific Pre Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 42. Asia Pacific Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43. Asia Pacific Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 44. China Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45. India Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46. Japan Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47. Australia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48. South Korea Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49. Middle East & Africa Pre Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 50. Middle East & Africa Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51. Middle East & Africa Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 52. South Africa Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53. Saudi Arabia Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54. UAE Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55. South and Central America Pre Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 56. South and Central America Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57. South and Central America Pre Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 58. Argentina Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59. Brazil Pre Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60. Growth Strategies in the Pre Clinical CROs Market, 2016-2019

Figure 61. Organic Growth Strategies in the Pre Clinical CROs Market, 2016-2019 (%)

Figure 62. Inorganic Developments in the Pre Clinical CROs Market, 2016-2019(%)

The List of Companies

  1. Covance, Inc.
  2. Charles River
  3. Eurofins Scientific
  4. PRA Health Sciences
  5. WuXi AppTec
  6. Medpace, Inc.
  7. Pharmaceutical Product Development, LLC
  8. Parexel International Corporation
  9. ICON Plc
  10. MD Biosciences
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pre-clinical CROs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pre-clinical CROs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003316
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.